Amicus Therapeutics (FOLD) Reports Better-Than-Expected Q2 Adj-Loss of $0.51

August 5, 2009 5:14 PM EDT Send to a Friend

Amicus Therapeutics (Nasdaq: FOLD) reports Q2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Amicus Therapeutics (FOLD) Reports Better-Than-Expected Q2 Adj-Loss of $0.51

Member Login

Free News Feed